M-O-O-D: That is the important word right here. And, what a difference a few weeks makes for last week the markets seemed to switch from the “glass being half-empty to half-full” leaving Mr. Market in a more forgiving mood. Importantly, market mood frequently sets the near-term trend. If the mood is positive, all things are possible; if it is negative, little is. To wit, consider the following excerpt on mood from the New York Times:

‘Emotions are contagious,’ wrote the Swiss psychoanalyst Carl Jung. His observation is now being borne out and given precision by scientific studies of the subtle interplay of moods as they are passed from person to person. . . . It is perhaps no surprise that people’s moods affect how they see their futures. But psychologists point out that people are largely unaware that a good or bad mood is creating an optimistic or pessimistic outlook. . . . Research shows that moods influence people’s judgments by making either positive or negative memories more readily available. Thus a rational weighing of the evidence is swayed in one direction or the other by the bias that moods introduce in what can be brought to minds.

Obviously the mood momentum has shifted over the past few weeks and now seems to favor the bulls as indicated by +6% rally from the S&P 500’s (SPX/1342.84) intraday low on June 4th (1266.74) into last Friday’s intraday high of 1343.32. To be sure, the mood change has been driven by rumors out of Europe that the central banks stand ready to supply enough money to “paper over” the near-term consternations of Euroquake. Why this should come as a surprise is a mystery to me because you don’t throw a trillion dollars at a problem and then just walk away if it doesn’t solve the problem. We didn’t do that with our financial fiasco and the Europeans won’t do it with theirs. Indeed, over the past few weeks rumors have swirled that another two trillion dollars are being readied for Euroquake, and if that doesn’t solve the issues I think even more money will be thrown at the situation. And, here’s the twist: it is likely our Federal Reserve will have to provide a liquidity event of its own to keep the U.S. dollar from spiking higher. Clearly, that appears to be what the weakening U.S. Dollar Index seems to be sensing as can be seen in the attendant chart.

Plainly, the past two weeks’ stock market action has been impressive as bad news has been ignored for the first time in two months. For example, the string of bad economic news continued last week with 10 of the 16 economic reports coming in worse than expected; four were in line, but only two came in above estimates. While that was better than the previous week’s pathetic parade of releases, it is still far from being good. Nevertheless, most of the indices I monitor moved higher again last week (second week in a row). In fact, the only indexes in my universe that fell were the S&P MidCap 400 (MID/920.26) and the S&P SmallCap 600 (SML/430.25). Of the major indices the D-J Industrial Average (INDU/12767.17) faired the best by gaining 1.70% and in the process broke above its 50-day moving average (DMA) at 12752.37. This was the first close above its 50-DMA since the decline began in earnest on May 4th and should therefore be viewed constructively. It also lifted the SPX above its overhead resistance between 1335 and 1340 so often referenced in these comments. Still, to match the INDU move the SPX will have to better its respective 50- DMA at 1348.45. As for sectors, last week’s most winning sectors were Telecommunication Services (+3.11%) and Energy (+2.47%). Regrettably, however, the two week rally has left no sectors currently oversold and Consumer Staples, Telecommunication Services and Utilities pretty overbought. Similarly, the NYSE McClellan Oscillator is overbought (see chart).

Since the SPX’s June 4th “low” of ~1266, I have repeatedly opined that I am treating said low as a daily/intermediate-term low even though the violation of my 1290 pivot point caused me to suspend the program of recommitting some of the cash raised between February and April. As stated, “In this business it’s better to lose ‘face’ and save ‘skin’!” And clearly the decline of ~11% exceeded my expectations of a 5% - 8% affair. That’s why investors need to have the discipline to adapt to whatever is happening in the various markets. But, what inevitably happens when a portfolio begins to erode, investors are told, “No one can time the market; and it is time in the market not timing the market.” Or, “If you miss the 10 best days in the market, your investment returns fall significantly.” Of course, investors are never told that if you miss the 10 worst days your returns swamp the return of investors who stayed the course and rode the “ups,” as well as the “downs.” Now I admit, n-o-b-o-d-y can consistently “time” the market on a daily or a weekly basis; yet, there are numerous indicators that tell us when we should be aggressive, and when we should be defensive. Those indicators are what caused us to raise cash every spring for the past three years. Moreover, you can pretty much count on me to sell 25% – 33% of any portfolio position if it is up 100% to rebalance that position; and, I don’t really care if the gain is long-term or not. You can also count on me to take some kind of defensive action (sell, hedge, collar, etc.) when something goes against me between 15% – 20%. Indeed, avoiding the big loss is the key to better returns in the markets.

So where does all this leave us currently? Well, plainly the markets will put rabbit ears on for the Greek elections. As I write, the polls suggest the center-right New Democracy party has a slight lead. If so, markets are likely to react positively because although this would be the same election outcome as last month, this time it should produce a stronger government coalition. However, if the left-wing Syriza party wins, the markets should react negatively as Syriza has threatened to stop all austerity programs. And when I arrived in the office at 5:30 a.m. this morning, the headline reads, “Greece’s New Democracy party seeks bailout coalition.” While that election is a relief, the more important election may be what happened in France where newly elected President Hollande solidified his left-wing leaning with a comfortable win by the socialists in Parliament. Then there is the election in Egypt where the Muslim Brotherhood appears to have won. Yet to me, the real surprise is likely to be our election this November.

As the astute GaveKal organization opines, “I think the surprise is going to be America and the surprise is going to be the level of productivity the U.S. is going to deliver on the back of reindustrialization, cheaper energy, and smarter policymakers and smarter policies.” Indeed, history shows that you tend to get periods of governmental acrimony where nothing gets done – and we’ve had that. After the election, whoever gets elected, I think that a fair amount will be done to tackle the debt situation and increase the productivity of government. I love the good folks at GaveKal, as well as the way they manage money, which is why I embrace the GaveKal Platform Company Fund (GAVIX/$11.43), which is managed by my friend Steve Vannelli.

The call for today: The New Democracy’s narrow win in yesterday’s election should ease near-term worries of a Greek Gotcha’; yet, it does not take Euroquake off of the table. Moreover, the French and Egyptian elections have heightened international worries this morning leaving the preopening S&P 500 futures lower by about 5 points. Here in the U.S., investors will be listening to the Tuesday/Wednesday FOMC meeting to see if the Fed will indeed provide another liquidity event be it QE3, an extension of Operation Twist, or targeting GDP. Also on tap this week are the potentially market moving Philly Fed Index (Jun) and Leading Indicators (May) reports, not to forget the G20 meeting in Mexico. But remember, it is the stock market’s reaction to the news rather than the actual news that is important. Accordingly, watch the support level now at 1330 – 1340 to see if the market continues to ignore bad news. This week should tell us if this is a “fakeout” rally or something more.

Important Investor Disclosures

Raymond James & Associates (RJA) is a FINRA member firm and is responsible for the preparation and distribution of research created in the United States. Raymond James & Associates is located at The Raymond James Financial Center, 880 Carillon Parkway, St. Petersburg, FL 33716, (727) 567-1000. Non-U.S. affiliates, which are not FINRA member firms, include the following entities which are responsible for the creation and distribution of research in their respective areas; In Canada, Raymond James Ltd., Suite 2200, 925 West Georgia Street, Vancouver, BC V6C 3L2, (604) 659-8200; In Latin America, Raymond James Latin America, Ruta 8, km 17, 500, 91600 Montevideo, Uruguay, 00598 2 518 2033; In Europe, Raymond James Euro Equities, SAS, 40, rue La Boetie, 75008, Paris, France, +33 1 45 61 64 90.

This document is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation. The securities discussed in this document may not be eligible for sale in some jurisdictions. This research is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. Investors should consider this report as only a single factor in making their investment decision.

Investing in securities of issuers organized outside of the U.S., including ADRs, may entail certain risks. The securities of non-U.S. issuers may not be registered with, nor be subject to the reporting requirements of, the U.S. Securities and Exchange Commission. There may be limited information available on such securities. Investors who have received this report may be prohibited in certain states or other jurisdictions from purchasing the securities mentioned in this report. Please ask your Financial Advisor for additional details.

The information provided is as of the date above and subject to change, and it should not be deemed a recommendation to buy or sell any security. Certain information has been obtained from third-party sources we consider reliable, but we do not guarantee that such information is accurate or complete. Persons within the Raymond James family of companies may have information that is not available to the contributors of the information contained in this publication. Raymond James, including affiliates and employees, may execute transactions in the securities listed in this publication that may not be consistent with the ratings appearing in this publication.

Additional information is available on request.

Analyst Information

 
Registration of Non-U.S. Analysts: The analysts listed on the front of this report who are not employees of Raymond James & Associates, Inc., are not registered/qualified as research analysts under FINRA rules, are not associated persons of Raymond James & Associates, Inc., and are not subject to NASD Rule 2711 and NYSE Rule 472 restrictions on communications with covered companies, public companies, and trading securities held by a research analyst account.

Analyst Holdings and Compensation: Equity analysts and their staffs at Raymond James are compensated based on a salary and bonus system. Several factors enter into the bonus determination including quality and performance of research product, the analyst's success in rating stocks versus an industry index, and support effectiveness to trading and the retail and institutional sales forces. Other factors may include but are not limited to: overall ratings from internal (other than investment banking) or external parties and the general productivity and revenue generated in covered stocks.

The views expressed in this report accurately reflect the personal views of the analyst(s) covering the subject securities. No part of said person's compensation was, is, or will be directly or indirectly related to the specific recommendations or views contained in this research report. In addition, said analyst has not received compensation from any subject company in the last 12 months.

Ratings and Definitions

Raymond James & Associates (U.S.) definitions

Strong Buy (SB1) Expected to appreciate, produce a total return of at least 15%, and outperform the S&P 500 over the next six to 12 months. For higher yielding and more conservative equities, such as REITs and certain MLPs, a total return of at least 15% is expected to be realized over the next 12 months.

Outperform (MO2) Expected to appreciate and outperform the S&P 500 over the next 12-18 months. For higher yielding and more conservative equities, such as REITs and certain MLPs, an Outperform rating is used for securities where we are comfortable with the relative safety of the dividend and expect a total return modestly exceeding the dividend yield over the next 12-18 months.

Market Perform (MP3) Expected to perform generally in line with the S&P 500 over the next 12 months.

Underperform (MU4) Expected to underperform the S&P 500 or its sector over the next six to 12 months and should be sold.

Suspended (S) The rating and price target have been suspended temporarily. This action may be due to market events that made coverage impracticable, or to comply with applicable regulations or firm policies in certain circumstances, including when Raymond James may be providing investment banking services to the company. The previous rating and price target are no longer in effect for this security and should not be relied upon.

Raymond James Ltd. (Canada) definitions

Strong Buy (SB1) The stock is expected to appreciate and produce a total return of at least 15% and outperform the S&P/TSX Composite Index over the next six months.

Outperform (MO2) The stock is expected to appreciate and outperform the S&P/TSX Composite Index over the next twelve months.

Market Perform (MP3) The stock is expected to perform generally in line with the S&P/TSX Composite Index over the next twelve months and is potentially a source of funds for more highly rated securities.

Underperform (MU4) The stock is expected to underperform the S&P/TSX Composite Index or its sector over the next six to twelve months and should be sold.

Raymond James Latin American rating definitions

Strong Buy (SB1) Expected to appreciate and produce a total return of at least 25.0% over the next twelve months.

Outperform (MO2) Expected to appreciate and produce a total return of between 15.0% and 25.0% over the next twelve months.

Market Perform (MP3) Expected to perform in line with the underlying country index.

Underperform (MU4) Expected to underperform the underlying country index.

Suspended (S) The rating and price target have been suspended temporarily. This action may be due to market events that made coverage impracticable, or to comply with applicable regulations or firm policies in certain circumstances, including when Raymond James may be providing investment banking services to the company. The previous rating and price target are no longer in effect for this security and should not be relied upon.

Raymond James Euro Equities, SAS rating definitions

Strong Buy (1) Expected to appreciate, produce a total return of at least 15%, and outperform the Stoxx 600 over the next 6 to 12 months.

Outperform (2) Expected to appreciate and outperform the Stoxx 600 over the next 12 months.

Market Perform (3) Expected to perform generally in line with the Stoxx 600 over the next 12 months.

Underperform (4) Expected to underperform the Stoxx 600 or its sector over the next 6 to 12 months.

Suspended (S) The rating and target price have been suspended temporarily. This action may be due to market events that made coverage impracticable, or to comply with applicable regulations or firm policies in certain circumstances, including when Raymond James may be providing investment banking services to the company. The previous rating and target price are no longer in effect for this security and should not be relied upon.

In transacting in any security, investors should be aware that other securities in the Raymond James research coverage universe might carry a higher or lower rating. Investors should feel free to contact their Financial Advisor to discuss the merits of other available investments.

Suitability Categories (SR)

For stocks rated by Raymond James & Associates only, the following Suitability Categories provide an assessment of potential risk factors for investors. Suitability ratings are not assigned to stocks rated Underperform (Sell). Projected 12-month price targets are assigned only to
stocks rated Strong Buy or Outperform.

Total Return (TR) Lower risk equities possessing dividend yields above that of the S&P 500 and greater stability of principal.

Growth (G) Low to average risk equities with sound financials, more consistent earnings growth, possibly a small dividend, and the potential for long-term price appreciation.

Aggressive Growth (AG) Medium or higher risk equities of companies in fast growing and competitive industries, with less predictable earnings and acceptable, but possibly more leveraged balance sheets.

High Risk (HR) Companies with less predictable earnings (or losses), rapidly changing market dynamics, financial and competitive issues, higher price volatility (beta), and risk of principal.

Venture Risk (VR) Companies with a short or unprofitable operating history, limited or less predictable revenues, very high risk associated with success, and a substantial risk of principal.

Raymond James Relationship Disclosures

Raymond James expects to receive or intends to seek compensation for investment banking services from the subject companies in the next three months.

Risk Factors

Risk and Disclosure information, as well as more information on the Raymond James rating system and suitability categories, is available at rjcapitalmarkets.com/SearchForDisclosures_main.asp. Copies of research or Raymond James’ summary policies relating to research analyst independence can be obtained by contacting any Raymond James & Associates or Raymond James Financial Services office (please see raymondjames.com for office locations) or by calling 727-567-1000, toll free 800-237-5643 or sending a written request to the Equity Research Library, Raymond James & Associates, Inc., Tower 3, 6th Floor, 880 Carillon Parkway, St. Petersburg, FL 33716.

International securities involve additional risks such as currency fluctuations, differing financial accounting standards, and possible political and economic instability. These risks are greater in emerging markets. Small-cap stocks generally involve greater risks. Dividends are not guaranteed and will fluctuate. Past performance may not be indicative of future results.

Investors should consider the investment objectives, risks, and charges and expenses of mutual funds carefully before investing. The prospectus contains this and other information about mutual funds. The prospectus is available from your financial advisor and should be read carefully before investing.

For clients in the United Kingdom:

For clients of Raymond James & Associates (London Branch) and Raymond James Financial International Limited (RJFI): This document and any investment to which this document relates is intended for the sole use of the persons to whom it is addressed, being persons who are Eligible Counterparties or Professional Clients as described in the FSA rules or persons described in Articles 19(5) (Investment professionals) or 49(2) (High net worth companies, unincorporated associations etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or any other person to whom this promotion may lawfully be directed. It is not intended to be distributed or passed on, directly or indirectly, to any other class of persons and may not be relied upon by such persons and is therefore not intended for private individuals or those who would be classified as Retail Clients.

For clients of Raymond James Investment Services, Ltd.: This report is for the use of professional investment advisers and managers and is not intended for use by clients.

For purposes of the Financial Services Authority requirements, this research report is classified as independent with respect to conflict of interest management. RJA, RJFI, and Raymond James Investment Services, Ltd. are authorised and regulated by the Financial Services Authority in the United Kingdom.

For clients in France:

This document and any investment to which this document relates is intended for the sole use of the persons to whom it is addressed, being persons who are Eligible Counterparties or Professional Clients as described in “Code Monétaire et Financier” and Règlement Général de l’Autorité des Marchés Financiers. It is not intended to be distributed or passed on, directly or indirectly, to any other class of persons and may not be relied upon by such persons and is therefore not intended for private individuals or those who would be classified as Retail Clients.

For institutional clients in the European Economic Area (EEA) outside of the United Kingdom:

This document (and any attachments or exhibits hereto) is intended only for EEA institutional clients or others to whom it may lawfully be
submitted.

For Canadian clients:

Review of Material Operations: The Analyst and/or Associate is required to conduct due diligence on, and where deemed appropriate visit, the material operations of a subject company before initiating research coverage. The scope of the review may vary depending on the complexity of the subject company’s business operations. This report is not prepared subject to Canadian disclosure requirements.

For Latin American clients:

Registration of Brazil-based Analysts: In accordance with Regulation #483 issued by the Brazil Securities and Exchange Commission (CVM) in October 2010, all lead Brazil-based Research Analysts writing and distributing research are CNPI certified as required by Art. 1 of APIMEC’s Code of Conduct www.apimec.com.br/supervisao/codigodeconduta). They abide by the practices and procedures of this regulation as well as internal procedures in place at Raymond James Brasil S.A. A list of research analysts accredited with the APIMEC can be found on the webpage (www.apimec.com.br/ certificacao/Profissionais Certificados). Non-Brazil-based analysts writing Brazil research and or making sales efforts with the same are released from these APIMEC requirements as stated in Art. 20 of CVM Instruction #483, but abide by recognized Codes of Conduct, Ethics and Practices that comply with Articles 17, 18, and 19 of CVM Instruction #483.

Proprietary Rights Notice: By accepting a copy of this report, you acknowledge and agree as follows:

This report is provided to clients of Raymond James only for your personal, noncommercial use. Except as expressly authorized by Raymond James, you may not copy, reproduce, transmit, sell, display, distribute, publish, broadcast, circulate, modify, disseminate or commercially exploit the information contained in this report, in printed, electronic or any other form, in any manner, without the prior express written consent of Raymond James. You also agree not to use the information provided in this report for any unlawful purpose. This is RJA client releasable research

This report and its contents are the property of Raymond James and are protected by applicable copyright, trade secret or other intellectual property laws (of the United States and other countries). United States law, 17 U.S.C. Sec.501 et seq, provides for civil and criminal penalties for copyright infringement.

 

(c) Raymond James

www.raymondjames.com